Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apert Syndrome”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableLooking for participantsNCT07535372
What this trial is testing

ASO Treatment for Syndromic Craniosynostoses

Who this might be right for
CraniosynostosesCrouzon SyndromeSaethre Chotzen Syndrome+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 12
Testing effectiveness (Phase 2)Ended earlyNCT04003610
What this trial is testing

Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)

Who this might be right for
Metastatic Urothelial CarcinomaUnresectable Urothelial Carcinoma
Incyte Corporation 7
Not applicableUnknownNCT04725851
What this trial is testing

High Concentration Oxygen for Pneumocephalus After Evacuation of Chronic Subdural Haematoma

Who this might be right for
Chronic Subdural HematomaRecurrenceOxycephaly
Chinese University of Hong Kong 36
Early research (Phase 1)Study completedNCT01928459
What this trial is testing

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Novartis Pharmaceuticals 62
Early research (Phase 1)Ended earlyNCT03144661
What this trial is testing

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more
Incyte Corporation 25
Not applicableNot Yet RecruitingNCT06322758
What this trial is testing

Driving Pressure-guided Tidal Volume Ventilation in the Acute Respiratory Distress Syndrome

Who this might be right for
Acute Respiratory Distress Syndrome ARDS
Assistance Publique - Hôpitaux de Paris 750
Not applicableUnknownNCT01927354
What this trial is testing

Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.

Who this might be right for
Head-and-Neck Squamous Cell Carcinoma
National Taiwan University Hospital 100
Not applicableStudy completedNCT03955913
What this trial is testing

Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations

Who this might be right for
Urothelial CancerReceptors, Fibroblast Growth Factor
Janssen Research & Development, LLC 3,679
Testing effectiveness (Phase 2)Ended earlyNCT01367275
What this trial is testing

Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF

Who this might be right for
Colorectal CancerColorectal Adenocarcinoma
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT03822117
What this trial is testing

Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

Who this might be right for
Solid Tumor Malignancy
Incyte Corporation 111
Testing effectiveness (Phase 2)WithdrawnNCT02747797
What this trial is testing

Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations

Who this might be right for
Advanced Cancer
Teresa Helsten, MD
Testing effectiveness (Phase 2)Study completedNCT02699606
What this trial is testing

Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma

Who this might be right for
Neoplasm
Janssen Research & Development, LLC 35
Large-scale testing (Phase 3)Looking for participantsNCT07710885
What this trial is testing

Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Taiho Pharmaceutical Co., Ltd. 784
Early research (Phase 1)Study completedNCT03235570
What this trial is testing

A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)

Who this might be right for
Solid Tumors
Incyte Corporation 44
Testing effectiveness (Phase 2)Study completedNCT04045613
What this trial is testing

Derazantinib and Atezolizumab in Patients With Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Basilea Pharmaceutica 95
Testing effectiveness (Phase 2)Study completedNCT02924376
What this trial is testing

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Who this might be right for
Cholangiocarcinoma
Incyte Corporation 147
Testing effectiveness (Phase 2)Study completedNCT02872714
What this trial is testing

Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

Who this might be right for
UC (Urothelial Cancer)
Incyte Corporation 263
Testing effectiveness (Phase 2)Ended earlyNCT04604132
What this trial is testing

Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Basilea Pharmaceutica 47
Not applicableEnded earlyNCT00213889
What this trial is testing

TWIST Human Gene and Cleft Lips and Palates

Who this might be right for
Cleft Lip
University Hospital, Strasbourg, France 45
Testing effectiveness (Phase 2)Study completedNCT04238715
What this trial is testing

E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion

Who this might be right for
Cholangiocarcinoma
Eisai Co., Ltd. 63
Next Page